OFLOXACINE VIATRIS 1.5 mg/0.5 ml, ear solution in a single-dose container 20 single-dose containers of 0.5 ml
Active ingredients: OFLOXACINE
Commercialized according to BDPMDispensing in France: Prescription only
Solution20 single-dose containers of 0.5 mlauriculaire
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- OFLOXACINE VIATRIS 1,5 mg/0,5 mL, solution auriculaire en récipient unidose
- Pharmaceutical form
- solution
- Route of administration
- auriculaire
- Presentation description
- 20 récipients unidoses polyéthylène de 0,5 mL
- Marketing authorisation holder
- VIATRIS SANTE
- Reimbursement according to BDPM
- 30 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 8 Nov 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63535151CIP73023683CIP133400930236833Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| OFLOXACINEsolution | 1,5 mg · un récipient unidose de 0,5 mL | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
Group of similar medicines: OFLOXACINE 1,5 mg/0,5 ml - OFLOCET 1,5 mg/0,5 ml, solution auriculaire en récipient unidose.